SCHEMBL25967975

SCHEMBL25967975

CCc1cc(-c2ccccc2C)[n+](C)cc1CC(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.32
CA12 O43570 1/20 0.32
CA9 Q16790 1/20 0.32
NPC1 O15118 2/20 0.30
ALDH1A1 P00352 2/20 0.30
LMNA P02545 2/20 0.30
RAB9A P51151 2/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
MAPK1 P28482 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
PPARG P37231 1/20 0.30
PPARA Q07869 1/20 0.30
NR3C1 P04150 1/20 0.30
PGR P06401 1/20 0.30
NR3C2 P08235 1/20 0.30
GABRA1 P14867 1/20 0.30
GABRB2 P47870 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
APAF1 O14727 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25445929 0.93 GABRA1 (0.33) CA12CA9GABRA1GABRB2
SCHEMBL25967878 0.88 MAPT (0.35) MAPTCA12CA9NPC1ALDH1A1
SCHEMBL25885057 0.87 GABRA1 (0.33) CA12CA9GABRA1GABRB2
SCHEMBL25445928 0.87 GABRA1 (0.33) CA12CA9GABRA1GABRB2
SCHEMBL25638907 0.82 CA12 (0.33) MAPTCA12CA9NPC1ALDH1A1
SCHEMBL25446020 0.82 CA12 (0.33) MAPTCA12CA9NPC1ALDH1A1
SCHEMBL25967919 0.82 CNR2 (0.33) MAPTCA12CA9NPC1ALDH1A1
SCHEMBL25967922 0.82 CNR2 (0.33) MAPTCA12CA9NPC1ALDH1A1
SCHEMBL26014285 0.81 NPC1 (0.31) CA12CA9NPC1RAB9ASMN1; SMN2
SCHEMBL26013135 0.81 NPC1 (0.31) CA12CA9NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230209990-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230209990-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES L3MBTL3, AGO2, ELAVL3 MAPT 3793/4885CA12 1328/4885CA9 1834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.